Headache therapy with neuronal stabilising drugs

Neurological Sciences

Volumn 29, Issue SUPPL. 1, 2008, Pages

  Colombo, Bruno ^a   Libera, Dacia ^a   Annovazzi, Pietro Oreste ^a   Comi, Giancarlo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Antiepileptic drugs; Headache; Prophylaxis; Therapy

Indexed keywords

ANTICONVULSIVE AGENT; CENTRAL DEPRESSANT AGENT; CONTRACEPTIVE AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PLACEBO; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROATE SEMISODIUM; VALPROIC ACID;

ADD ON THERAPY; AGGRESSIVENESS; ALOPECIA; ANOREXIA; ARTICLE; ATAXIA; ATTENTION DISTURBANCE; CHRONIC DISEASE; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CLUSTER HEADACHE; COGNITIVE DEFECT; CONSTIPATION; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIPLOPIA; DIZZINESS; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; HEADACHE; HIGH RISK PATIENT; HUMAN; HYPERANDROGENISM; INSOMNIA; IRRITABILITY; LANGUAGE DISABILITY; LOW DRUG DOSE; MEASLES LIKE RASH; MEMORY DISORDER; MIGRAINE; MYOPIA; NAUSEA; NEPHROLITHIASIS; NERVE CELL EXCITABILITY; NEUROMODULATION; OVARY INSUFFICIENCY; PAIN ASSESSMENT; PARESTHESIA; RISK REDUCTION; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; TASTE DISORDER; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; HEADACHE; HUMANS;

EID: 45249111993     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-008-0904-7     Document Type: Article

References (46)

1. Colombo B, Annovazzi PO, Comi G. (2006) Medications for neuropathic pain: Current trends. Neurol Sci 27[Suppl2]:S183-S189
2. Welch KM (2003) Contemporary concepts of migraine pathogenesis. Neurology 61[Suppl]:S2-S8
3. Silberstein SD (2006) Preventive treatment of migraine. Trends Pharmacol Sci 27:410-415
4. Pietrobon D (2005) Migraine: New molecular mechanisms. Neuroscientist 11:373-386
5. D'Amico D (2007) Antiepileptic drugs in the prophylaxis of migraine, chronic headache forms and cluster headache: A review of their efficacy and tolerability. Neurol Sci 28[Suppl 2]:S188-S197
6. Sorensen KV (1988) Valproate: A new drug in migraine prophylaxis. Acta Neurol Scand 78:346-348
7. Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo. Cephalalgia 12:81-84
8. Jensen R, Brinck T, Olesen J (1994) Sodium valproate has a prophylactic effect in migraine without aura: A triple-blind, placebo-controlled crossover study. Neurology 44:647-651
9. Mathew NT, Saper JR, Silberstein SD et al (1995) Migraine prophylaxis with divalproex. Arch Neurol 52:281-286
10. Klapper J (1997) Divalproex sodium in migraine prophylaxis: A dose-controlled study. Cephalalgia 17:103-108
11. Freitag FG, Collins SD, Carlson HA et al (2002) A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology 58:1652-1659
12. Freitag FG, Diamond S, Diamond ML, Urban GJ (2001) Divalproex in the long-term treatment of chronic daily headache. Headache 41:271-278
13. El Amrani M, Massiou H, Bousser MG (2002) A negative trial of sodium valproate in cluster headache: Methodological issues. Cephalalgia 22:205-208
14. Silberstein SD, Neto W, Schmitt J, Jacobs D (2004) Topiramate in migraine prevention: Results of a large controlled trial. Arch Neurol 61:490-495
15. Brandes JL, Saper JR, Diamond M et al (2004) Topiramate for migraine prevention: A randomized controlled trial. JAMA 291:965-973
16. Bussone G, Diener HC, Pfeil J, Schwalen S (2005) Topiramate 100 mg/day in migraine prevention: A pooled analysis of double-blind randomised controlled trials. Int J Clin Pract 59:961-968
17. Rapoport A, Mauskop A, Diener HC et al (2006) Long-term migraine prevention with topiramate: Open-label extension of pivotal trials. Headache 46:1151-1160
18. Diener HC, Tfelt-Hansen P, Dahlof C et al (2004) Topiramate in migraine prophylaxis - results from a placebo-controlled trial with propranolol as an active control. J Neurol 251:943-950
19. Gupta P, Singh S, Goyal V et al (2007). Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study). Headache 47:402-412
20. Diener HC, Bussone G, Van Oene JC et al (2007) Topiramate reduces headache days in chronic migraine: A randomized, double-blind, placebo-controlled study. Cephalalgia 27:814-823
21. Diener HC, Agosti R, Allais G et al (2007) Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): A randomised, double-blind, placebo-controlled trial. Lancet Neurol 6:1054-1062
22. Limmroth V, Biondi D, Pfeil J, Schwalen S (2007) Topiramate in patients with episodic migraine: Reducing the risk for chronic forms of headache. Headache 47:13-21
23. Lewis D, Paradiso E (2007) A double-blind, dose comparison study of topiramate for prophylaxis of basilar-type migraine in children: A pilot study. Headache 47:1409-1417
24. Mathew NT, Kailasam J, Meadors L (2002) Prophylaxis of migraine, transformed migraine, and cluster headache with topiramate. Headache 42:796-803
25. Wheeler SD, Carrazana EJ (1999) Topiramate-treated cluster headache. Neurology 53:234-236
26. Forderreuther S, Mayer M, Straube A (2002) Treatment of cluster headache with topiramate: Effects and side-effects in five patients. Cephalalgia 22:186-189
27. Lainez MJ, Pascual J, Pascual AM et al (2003) Topiramate in the prophylactic treatment of cluster headache. Headache 43:784-789
28. Leone M, Dodick D, Rigamonti A et al (2003) Topiramate in cluster headache prophylaxis: An open trial. Cephalalgia 23:1001-1002
29. Autunno M, Messina C, Blandino A, Rodolico C (2008) Hypnic headache responsive to low-dose topiramate: A case report. Headache 48:292-294
30. Brown JS, Papadopoulos G, Neumann PJ et al (2005) Cost-effectiveness of topiramate in migraine prevention: Results from a pharmacoeconomic model of topiramate treatment. Headache 45:1012-1022
31. Dahlof C, Loder E, Diamond M et al (2007) The impact of migraine prevention on daily activities: A longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health Qual Life Outcomes 5:56
32. Winner P, Gendolla A, Stayer C et al (2006) Topiramate for migraine prevention in adolescents: A pooled analysis of efficacy and safety. Headache 46:1503-1510
33. Silberstein SD, Feliu AL, Rupnow MF et al (2007) Topiramate in migraine prophylaxis: Long-term impact on resource utilization and cost. Headache 47:500-510
34. Steiner TJ, Findley LJ, Yuen AW (1997) Lamotrigine versus placebo in the prophylaxis of migraine with and without aura. Cephalalgia 17:109-112
35. D'Andrea G, Granella F, Cadaldini M, Manzoni GC (1999) Effectiveness of lamotrigine in the prophylaxis of migraine with aura: An open pilot study. Cephalalgia 19:64-66
36. Lampl C, Buzath A, Klinger D, Neumann K (1999) Lamotrigine in the prophylactic treatment of migraine aura - a pilot study. Cephalalgia 19:58-63
37. D'Andrea G, Bussone G, Granella F et al (2000) Treatment of SUNCT syndrome with lamotrigine. Cephalalgia 20:377-384
38. D'Andrea G, Granella F, Cadaldini M (1999) Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 53:1609-1639
39. Di Trapani G, Mei D, Marra C et al (2000) Gabapentin in the prophylaxis of migraine: A double-blind randomized placebocontrolled study. Clin Ter 151:145-148
40. Mathew NT, Rapoport A, Saper J et al (2001) Efficacy of gabapentin in migraine prophylaxis. Headache 41:119-128
41. Spira PJ, Beran RG (2003) Gabapentin in the prophylaxis of chronic daily headache: A randomized, placebo-controlled study. Neurology 61:1753-1759
42. Leandri M, Luzzani M, Cruccu G, Gottlieb A (2001) Drug-resistant cluster headache responding to gabapentin: A pilot study. Cephalalgia 21:744-746
43. Krusz JC (2001) Levetiracetam as prophylaxis for resistant headaches. Cephalalgia 21:373
44. Drake, ME, Greathouse NI, Armentbright AD, Renner JB (2001) Levetiracetam for preventive treatment of migraine. Cephalalgia 21:373
45. Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (2005) Levetiracetam in the preventive treatment of transformed migraine. Curr Ther Res 66:212-222
46. Pakalnis A, Kring D, Meier L (2007) Levetiracetam prophylaxis in pediatric migraine-an open-label study. Headache 47:427-430